Results 121 to 130 of about 359,805 (237)

“The future of death in the present of love”: Eros as an ethical pas encore in Levinas's Totality and Infinity

open access: yesThe Southern Journal of Philosophy, EarlyView.
Abstract This article reinterprets Levinas's account of ethical subjectivity by centering the temporality of the pas encore (“not yet”) and drawing on new materials in Œuvres complètes. I argue that, in Totality and Infinity, eros and ethics are internally continuous: eros generates a responsible not yet of time, secured by fecundity and oriented to ...
Huaiyuan Zhang
wiley   +1 more source

Winged horses, rascals and discourse referents

open access: yesTheoria, EarlyView.
Abstract This paper discusses some remarks Kaplan made in ‘Bob and Carol and Ted and Alice’ concerning empty names. I show how his objections to a particular view involving descriptions derived from Ramsification can be avoided by a nearby alternative framed in terms of discourse reference.
Andreas Stokke
wiley   +1 more source

Varieties of Authoritarian Policymaking: Housing Policy Across Dictatorships

open access: yesGovernance, Volume 39, Issue 3, July 2026.
ABSTRACT Public policies are expected to vary across regime types, but this association remains inconclusive even when further differentiating within types of authoritarian regimes. Focusing on the theoretical mechanisms behind the expected associations between regime type and policy, I propose a novel framework to analyze policymaking and outputs ...
Emilia Simison
wiley   +1 more source

From Concept to Clinic: Pre‐Clinical Testing and Regulatory Considerations in Spine Implant Development

open access: yesJOR SPINE, Volume 9, Issue 2, June 2026.
Spine implant development follows a regulated, iterative pathway from clinical need and design through material selection, prototyping, preclinical validation, and regulatory approval to post‐market surveillance. Biomechanical evaluation and risk‐based frameworks integrate across all stages, ensuring safe, effective translation from concept to clinical
Amit Benady   +5 more
wiley   +1 more source

Advancing Pharmacometrics in Africa: Insights and Perspectives From the 2025 Pharmacometrics Africa Conference

open access: yesClinical Pharmacology &Therapeutics, Volume 119, Issue 5, Page 1216-1222, May 2026.
Pharmacometrics (PMX) in Africa has transitioned from foundational capacity‐building to job creation, scientific leadership, regulatory influence, and health innovation. To accelerate this progress, the 2025 Pharmacometrics Africa Conference (PMXAC‐2025) convened key stakeholders to consolidate the continental PMX community, review progress in local ...
Babatunde Ayodeji Adeagbo   +12 more
wiley   +1 more source

Global field trials show the advantages of beta regression compared with logit transformation and quasi‐likelihood for the analysis of percentage plant disease severity

open access: yesAnnals of Applied Biology, Volume 188, Issue 3, Page 904-916, May 2026.
Disease severity in crop protection field trials is commonly assessed as a proportion represented as a percentage. Traditional statistical analysis uses transformation to logit or angle. This study compares analyses based on the beta distribution and the quasi‐likelihood method with the logit transform using a large global data set of field trials ...
Boby Mathew   +2 more
wiley   +1 more source

Dossier

open access: yes, 2021
Tymen Peverelli   +3 more
openaire   +3 more sources

La Reforma Universitaria en su centenario

open access: yesRecial, 2018
Sin duda la elocuencia y magnificencia de los primeros párrafos del Manifiesto Liminar nos permiten asumir, como propone Iván Jablonka, que la historia es la literatura contemporánea.
Alicia Rubio
doaj  

Advancing Pharmacoequity in Low‐ and Middle‐Income Countries via Model Informed Drug Development

open access: yesClinical and Translational Science, Volume 19, Issue 5, May 2026.
ABSTRACT Across low‐ and middle‐income countries (LMICs) inequities in access to safe, effective medicines persist due to limited regulatory capacity, inadequate financing, and insufficient local data. Regulatory authorities are engaging with model‐informed drug development (MIDD), but uneven technical readiness and resource gaps limit uptake ...
Henry Enzama   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy